endometrial squamous cell carcinoma (Cancer)
Information
- Disease name
- endometrial squamous cell carcinoma
- Disease ID
- DOID:5533
- Description
- "An endometrial carcinoma that has_material_basis_in squamous cells." [url:https\://www.ncbi.nlm.nih.gov/pubmed/24615329]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00492778 | Active, not recruiting | Phase 2 | Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer | February 25, 2008 | |
| NCT00575952 | Completed | Phase 1 | Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer | January 17, 2008 | July 16, 2016 |
| NCT00888173 | Completed | Phase 2 | Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer | July 6, 2009 | July 16, 2016 |
| NCT01225887 | Completed | Phase 2 | Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer | October 2011 | January 2016 |
| NCT01440998 | Completed | Phase 1 | Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer | September 20, 2011 | December 31, 2015 |
| NCT01642082 | Completed | Phase 2 | Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer | September 2012 | January 2016 |
- Disase is a (Disease Ontology)
- DOID:2871
- Cross Reference ID (Disease Ontology)
- NCI:C8719
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:733359005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C1333396
- Exact Synonym (Disease Ontology)
- squamous cell carcinoma of Endometrium